Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[11C]verapamil PET
From: 16th Scientific Symposium of the Austrian Pharmacological Society (APHAR) Vienna, Austria 25-27 November 2010 Author details 1-Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria EMPTY 2-Department of Nuclear Medicine, Medical University of Vienna, 1090 Vien...
Gespeichert in:
Veröffentlicht in: | BMC pharmacology 2010-11, Vol.10 (S1), p.A47-A47, Article A47 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | From: 16th Scientific Symposium of the Austrian Pharmacological Society (APHAR) Vienna, Austria 25-27 November 2010 Author details 1-Department of Clinical Pharmacology, Medical University of Vienna, 1090 Vienna, Austria EMPTY 2-Department of Nuclear Medicine, Medical University of Vienna, 1090 Vienna, Austria EMPTY 3-Health and Environment Department, Molecular Medicine, AIT Austrian Institute of Technology GmbH, 2444 Seibersdorf, AustriaEMPTY Supplemental Information: |
---|---|
ISSN: | 1471-2210 1471-2210 |
DOI: | 10.1186/1471-2210-10-S1-A47 |